微门户首页  新闻  讨论区  活动  博客  求职招聘  行业报告  圈内成员  供应   
已读[804] 发布: 2013/05/08 15:06:12
头孢西丁钠和头孢唑肟钠制剂等品种是目前的主推品种,具有较高的知名度和市场覆盖率;氨曲南和美罗培南有望成为公司未来新的业绩增长点。同时公司向上游整合头孢产业...
已读[601] 发布: 2013/05/08 15:06:10
头孢西丁钠和头孢唑肟钠制剂等品种是目前的主推品种,具有较高的知名度和市场覆盖率;氨曲南和美罗培南有望成为公司未来新的业绩增长点。同时公司向上游整合头孢产业...
已读[182] 发布: 2013/05/07 16:39:23
Zacks.com While ezetimibe will help inhibit the absorption of cholesterol in the digestive tract, atorvastatin will inhibit the production of cholesterol in the liver. However, Liptruzet is yet to show any additional benefit compared to Lipitor where ... and more »
已读[102] 发布: 2013/05/07 16:10:07
已读[102] 发布: 2013/05/07 16:09:54
MedPage Today Vytorin, a combination of ezetimibe and simvastatin (Zocor), is another Merck product for high cholesterol. Vytorin has had its share of controversy over the years, in particular, a poor showing in the ENHANCE Trial, where it did not slow down the ...
已读[99] 发布: 2013/05/07 16:09:53
French Tribune Vytorin is another product by Merck for high cholesterol and it is a combination of ezetimibe and simvastatin . However, vytorin has been under controversies over the years for not slowing down the progression of atherosclerosis in Enhance trials. Filed ...
已读[90] 发布: 2013/05/07 16:09:52
FiercePharma The Zetia-plus-statin approach isn't new, of course; Merck ($MRK) already sells Vytorin, a combination of Zetia and its own off-patent statin Zocor, known generically as Simvastatin . And as experts note, the new drug--Liptruzet--comes with similar ...
已读[102] 发布: 2013/05/07 16:09:51
PMLiVE The new once-daily drug is a line extension to Merck's Vytorin product, which combines the active ingredient in Zetia (ezetimibe) with the company's own off-paten...
已读[562] 发布: 2013/05/07 15:22:27
医药工业转型升级,跨出抗生素领域:公司医药工业研发确立“仿制药、大品种、差异化”策略,目前申报生产的大品种仿制药有阿托伐他汀钙、氯吡格雷、阿卡波糖等;创新...
已读[107] 发布: 2013/05/06 16:29:15
« 上一页  |   查看结果281-290共306   |  下一页 »

新闻标签:

没有标签


最新报告


求职招聘